Therefore, while fetuin-A may serve as a potential biomarker in NAFLD, the conflicting findings above indicate that fetuin-A may not be a useful biomarker in ASCVD. The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.